Novelix Pharmaceuticals Ltd

📈 Key Insider Boosts Stake in Novelix Pharmaceuticals

- Vupparapalli Pavani, a promoter group member, was allotted 325,000 equity shares on February 12, 2026.

- Total shareholding rose from 400,000 to 725,000 shares post-allotment.

- Voting rights increased from 2.27% to 3.64% (on a total capital basis) and from 1.60% to 2.66% (diluted basis).

- Company’s equity share capital grew from ₹17.62 crore to ₹19.94 crore, with diluted capital at ₹26.69 crore including warrants.